المؤلفون: Julie Priest, Guillaume Germain, François Laliberté, Mei Sheng Duh, Malena Mahendran, Iman Fakih, Alan Oglesby

المصدر: Infectious Diseases and Therapy, Vol 12, Iss 8, Pp 2117-2133 (2023)

مصطلحات موضوعية: Dolutegravir/lamivudine, 2-drug regimen, Healthcare costs, HIV-1, Integrase strand transfer inhibitor, Single-tablet regimen, Infectious and parasitic diseases, RC109-216

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2193-8229Test; https://doaj.org/toc/2193-6382Test

الوصول الحر: https://doaj.org/article/38a79db97baf4f47b325076395e0f2f1Test

المؤلفون: Hernando Knobel, Esperanza Cañas-Ruano, Ana Guelar, Pablo Knobel, Judit Villar-García, Alicia González-Mena, Ceclia Canepa, Itziar Arrieta-Aldea, Augustin Marcos, Agustí Abalat-Torrres, Roberto Güerri-Fernández

المصدر: HIV Research & Clinical Practice, Vol 24, Iss 1 (2023)

مصطلحات موضوعية: switching antiretroviral therapy, optimizing antiretroviral therapy, dolutegravir/lamivudine, bictegravir/emtricitabine/tenofovir alafenamide, real-world data, Infectious and parasitic diseases, RC109-216

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2578-7470Test

الوصول الحر: https://doaj.org/article/8bd4cbdc05564a438f6ad7794e4d765aTest

المؤلفون: Maria Mazzitelli, Lolita Sasset, Samuele Gardin, Davide Leoni, Mattia Trunfio, Vincenzo Scaglione, Daniele Mengato, Elena Agostini, Eleonora Vania, Cristina Putaggio, Annamaria Cattelan

المصدر: Viruses, Vol 15, Iss 8, p 1740 (2023)

مصطلحات موضوعية: HIV, PLWH, dual therapy, elderly, dolutegravir/lamivudine, durability, Microbiology, QR1-502

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/1999-4915/15/8/1740Test; https://doaj.org/toc/1999-4915Test

الوصول الحر: https://doaj.org/article/b9cef129ec31487b9d6147009baf3239Test

المؤلفون: Chandasana, Hardik, Singh, Rajendra, Adkison, Kimberly, Ait-Khaled, Mounir, Pene Dumitrescu, Teodora

المصدر: Antimicrob Agents Chemother ; ISSN:1098-6596 ; Volume:68 ; Issue:5

مصطلحات موضوعية: HIV-1, dolutegravir/lamivudine fixed-dose combination, population pharmacokinetic

العلاقة: https://doi.org/10.1128/aac.01504-23Test; https://pubmed.ncbi.nlm.nih.gov/38587380Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11064544Test/

الإتاحة: https://doi.org/10.1128/aac.01504-23Test
https://pubmed.ncbi.nlm.nih.gov/38587380Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11064544Test/

المؤلفون: Turkova, Anna, Chan, Man K, Kityo, Cissy, Kekitiinwa, Adeodata R, Musoke, Philippa, Violari, Avy, Variava, Ebrahim, Archary, Moherndran, Cressey, Tim R, Chalermpantmetagul, Suwalai, Sawasdichai, Kanokkorn, Ounchanum, Pradthana, Kanjanavanit, Suparat, Srirojana, Sakulrat, Srirompotong, Ussanee, Welch, Steven, Bamford, Alasdair, Epalza, Cristina, Fortuny, Clàudia, Colbers, Angela, Nastouli, Eleni, Walker, Simon, Carr, Dan, Conway, Magda, Spyer, Moira J, Parkar, Nazia, White, Iona, Nardone, Alessandra, Thomason, Margaret J, Ferrand, Rashida A, Giaquinto, Carlo, Ford, Deborah, D3 trial team

المصدر: Contemporary Clinical Trials , Article 107540. (2024) (In press).

مصطلحات موضوعية: Adolescents, Children, Dolutegravir/lamivudine, HIV, Randomised control trial, Two-drug therapy

العلاقة: https://discovery.ucl.ac.uk/id/eprint/10191285Test/

الإتاحة: https://discovery.ucl.ac.uk/id/eprint/10191285Test/

المؤلفون: Ki Hyun Lee, Jinnam Kim, Jung Ah Lee, Chang Hyup Kim, Jin Young Ahn, Su Jin Jeong, Nam Su Ku, Jun Yong Choi, Joon-Sup Yeom, Young Goo Song, Jung Ho Kim

المصدر: Viruses, Vol 14, Iss 11, p 2558 (2022)

مصطلحات موضوعية: dolutegravir/lamivudine, HIV infection, Asia, effectiveness, safety, Microbiology, QR1-502

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/1999-4915/14/11/2558Test; https://doaj.org/toc/1999-4915Test

الوصول الحر: https://doaj.org/article/9eb14fb661a3413f83322f3fe22a7de6Test

المؤلفون: Santoro, Maria, Mercedes, Armenia, Daniele, Teyssou, Elisa, Santos, José, Ramón, Charpentier, Charlotte, Lambert-Niclot, Sidonie, Antinori, Andrea, Katlama, Christine, Descamps, Diane, Perno, Carlo, Federico, Calvez, Vincent, Paredes, Roger, Ceccherini-Silberstein, Francesca, Marcelin, Anne, Geneviève

المساهمون: Università degli Studi di Roma Tor Vergata Roma = University of Rome Tor Vergata, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), CHU Pitié-Salpêtrière AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Université Sorbonne Paris Nord, AP-HP - Hôpital Bichat - Claude Bernard Paris, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Saint-Antoine AP-HP, Sorbonne Université - Faculté de Médecine (SU FM), Sorbonne Université (SU), Istituto Nazionale di Malattie Infettive "Lazzaro Spallanzani" (INMI), IrsiCaixa (Institut de Recerca de la Sida)

المصدر: ISSN: 2213-7165.

مصطلحات موضوعية: M184V HIV drug resistance Dolutegravir Lamivudine Virological response Treatment optimization strategies, [SDV]Life Sciences [q-bio]

العلاقة: hal-03939401; https://hal.science/hal-03939401Test; https://hal.science/hal-03939401/documentTest; https://hal.science/hal-03939401/file/1-s2.0-S2213716522001898-main.pdfTest

الإتاحة: https://doi.org/10.1016/j.jgar.2022.07.022Test
https://hal.science/hal-03939401Test
https://hal.science/hal-03939401/documentTest
https://hal.science/hal-03939401/file/1-s2.0-S2213716522001898-main.pdfTest

المؤلفون: Hongzhou Lu, Jianjun Sun

المصدر: Drug Discoveries & Therapeutics. 2021, 15(4):225

المؤلفون: Mazzitelli, Maria, Sasset, Lolita, Gardin, Samuele, Leoni, Davide, Trunfio, Mattia, Scaglione, Vincenzo, Mengato, Daniele, Agostini, Elena, Vania, Eleonora, Putaggio, Cristina, Cattelan, Annamaria

المساهمون: Mazzitelli, Maria, Sasset, Lolita, Gardin, Samuele, Leoni, Davide, Trunfio, Mattia, Scaglione, Vincenzo, Mengato, Daniele, Agostini, Elena, Vania, Eleonora, Putaggio, Cristina, Cattelan, Annamaria

مصطلحات موضوعية: HIV, PLWH, dolutegravir/lamivudine, dual therapy, durability, elderly

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37632082; info:eu-repo/semantics/altIdentifier/wos/WOS:001055686700001; volume:15; issue:8; firstpage:1740; journal:VIRUSES; https://hdl.handle.net/11577/3492544Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85168753276

الإتاحة: https://doi.org/10.3390/v15081740Test
https://hdl.handle.net/11577/3492544Test

المؤلفون: Moti Ramgopal, Mark R. Underwood, Andrew R. Zolopa, Brian Wynne, Tulika Singh, Mezgebe Berhe, Marybeth Dalessandro, Jessica E. Matthews, Jean van Wyk, Konstantinos Angelis, Peter A. Leone, Charlotte-Paige Rolle, Anson K Wurapa, Deanna Merrill, Roberto Ortiz, Christopher Nguyen

المصدر: AIDS (London, England)

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Anti-HIV Agents, Pyridones, Immunology, HIV Infections, medicine.disease_cause, Piperazines, chemistry.chemical_compound, Internal medicine, Oxazines, medicine, Humans, Immunology and Allergy, two-drug regimen, Adverse effect, Hepatitis B virus, business.industry, test-and-treat, Lamivudine, Clinical Science, Resistance mutation, Rash, dolutegravir, Clinical trial, Regimen, Infectious Diseases, dolutegravir/lamivudine, chemistry, Dolutegravir, HIV-1, rapid initiation, Female, medicine.symptom, business, Heterocyclic Compounds, 3-Ring, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5058329d456eaa0186754d612b69040Test
https://doi.org/10.1097/qad.0000000000002979Test